JAPANESE FOUNDATION FOR CANCER RESEARCH
Patent Owner
Stats
- 15 US PATENTS IN FORCE
- 7 US APPLICATIONS PENDING
- Jan 04, 2018 most recent publication
Details
- 15 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 448 Total Citation Count
- Feb 03, 1983 Earliest Filing
- 25 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2016/0258,940 MULTIFUNCTIONAL METAL NANOSTRUCTURE AND METHOD FOR PRODUCING SAMEOct 17, 14Sep 08, 16[A61K, G01N]
2016/0002,699 METHOD FOR SCREENING FOOD INGREDIENTS AND FOOD COMPOSITIONSFeb 10, 14Jan 07, 16[C12Q, G01N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9798770 Information processing unit, information processing method, and programDec 06, 13Oct 24, 17[G06Q, G06T, G06F, G06K]
9135703 Information processing apparatus and information processing method and program for themSep 29, 11Sep 15, 15[G06T, A61B, G06K]
9110305 Microscope cell staining observation system, method, and computer program productNov 19, 10Aug 18, 15[H04N, G01N, G02B]
9105239 Image processing device, image processing method, recording medium, and programMay 22, 12Aug 11, 15[G09G]
8937653 Microscope system, specimen observing method, and computer-readable recording mediumAug 09, 11Jan 20, 15[H04N, G02B]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0185,223 Compositions Comprising RAC Mutants, and Methods of Use ThereofAbandonedJul 26, 13Jul 02, 15[A61K, C12Q, C12N, G01N, C07K]
2015/0110,882 MULTIFUNCTIONAL METALLIC NANOSTRUCTURE AND METHOD FOR MANUFACTURING THE SAMEAbandonedOct 18, 13Apr 23, 15[A61K, G01N]
2010/0322,502 MEDICAL DIAGNOSIS SUPPORT DEVICE, IMAGE PROCESSING METHOD, IMAGE PROCESSING PROGRAM, AND VIRTUAL MICROSCOPE SYSTEMAbandonedJun 16, 10Dec 23, 10[G06K]
2010/0291,242 ANTAGONIST AGAINST TOLERANCE TO ANTICANCER DRUGSAbandonedDec 28, 09Nov 18, 10[A61K, A61P]
2010/0272,334 Microscope System, Specimen Observation Method, and Computer Program ProductAbandonedJun 17, 10Oct 28, 10[G06T]
2010/0141,752 Microscope System, Specimen Observing Method, and Computer Program ProductAbandonedDec 02, 09Jun 10, 10[H04N, G09G]
2009/0202,569 Prophylactic/Therapeutic Agent for CancerAbandonedApr 06, 07Aug 13, 09[A61K, C07H, C12N, C07K]
2009/0155,241 Prophylactic/therapeutic agent for cancerAbandonedJul 22, 05Jun 18, 09[A61K, C07H, C12Q, C12N, C07C, G01N, C07K]
2008/0249,036 Antagonist Against Tolerance to Anticancer DrugsAbandonedAug 31, 05Oct 09, 08[A61K, C12Q, C12N, A61P, C07J]
2007/0238,098 Method and Kit for Predicting Adverse Side Effects of Paclitaxel TherapyAbandonedNov 05, 04Oct 11, 07[C12Q]
2004/0236,742 Clustering apparatus, clustering method, and clustering programAbandonedMar 05, 04Nov 25, 04[G06F]
5620868 Gene coded for interleukin-2 polypeptide, recombinant DNA carrying the said gene, a living cell line possessing the recombinant DNA, and method for producing interleukin-2 using the said cellExpiredDec 26, 91Apr 15, 97[C12P, C12N]
5216172 1,4-dihydropyridine-4-aryl-2,6-dimethyl-3,5-dicarboxylates useful as agents against drug resistant tumor cellsExpiredJan 28, 91Jun 01, 93[A61K, C07D]
5087560 Monoclonal antibody for use in drug resistant cancers and production thereofExpiredOct 01, 90Feb 11, 92[C12P, C12N, C12G]
4923871 Certain 2,6-dimethyl-4-(pyrazolo[1,5a]-pyridin-3-yl)1,4-dihydro-pyridine-3,5-dicarboxylate derivatives and compositions containing sameExpiredNov 25, 87May 08, 90[A61K, C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
